Search Results - "Bushera, H."

Temsirolimus-resistant, checkpoint-deficient, homeostatic cytokine-responsive autologous TH1/TC1 cells for therapy of relapsed, refractory multiple myeloma (RRMM) by Felizardo, T., Mosquera Limas, S., Zhu, N., Bushera, H., Glass, D., Hari, P., Dhakal, B., Fowler, D.H.

Get full text

Induced hybrid Treg/Th2 RAPA-501 cells for therapy of amyotrophic lateral sclerosis (ALS) by Felizardo, T., Berry, J., Mosquera Limas, S., Zhu, N., Bushera, H., Glass, D., Munshi, P., Rowley, S., Korngold, R., Donato, M., Glass, J., Fowler, D.H.

Get full text

In vivo biologic activity of induced hybrid TREG/Th2 RAPA-501 cells for als therapy: correction of TSCM:TEMimbalance, normalization of IL-6 secretion, and reduction in serum NF-L levels by Felizardo, T., Lum, L.G., Ashmaig, M., Mosquera Limas, S., Zhu, N., Bushera, H., Glass, D., Berry, J., Korngold, R., Donato, M., Glass, J., Munshi, P., Rowley, S., Fowler, D.H.

Get full text